<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">geriatr</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гериатрической медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Geriatric Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2686-8636</issn><issn pub-type="epub">2686-8709</issn><publisher><publisher-name>Сайт издателя</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37586/2686-8636-4-2025-527-537</article-id><article-id custom-type="elpub" pub-id-type="custom">geriatr-601</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Гериатрический взгляд на спирометрический паттерн PRISm</article-title><trans-title-group xml:lang="en"><trans-title>A Geriatric Perspective on the PRISm Spirometry Pattern</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8737-4264</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеева</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeeva</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергеева Виктория Алексеевна</p><p>Самара</p></bio><bio xml:lang="en"><p>Sergeeva Victoria Alekseevna</p><p>Samara</p></bio><email xlink:type="simple">sergeeva.va@staff.sgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0027-1786</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Булгакова</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bulgakova</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самара</p></bio><bio xml:lang="en"><p>Samara</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО Саратовский ГМУ им. В. И. Разумовского Минздрава России<country>Россия</country></aff><aff xml:lang="en">Saratov State Medical University n.a. V.I. Razumovsky, Healthcare Ministry of Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО СамГМУ Минздрава России<country>Россия</country></aff><aff xml:lang="en">Samara State Medical University, Healthcare Ministry of Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2025</year></pub-date><volume>0</volume><issue>4</issue><fpage>527</fpage><lpage>537</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сергеева В.А., Булгакова С.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Сергеева В.А., Булгакова С.В.</copyright-holder><copyright-holder xml:lang="en">Sergeeva V.A., Bulgakova S.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.geriatr-news.com/jour/article/view/601">https://www.geriatr-news.com/jour/article/view/601</self-uri><abstract><p>Спирометрический паттерн PRISm остается камнем преткновения клиницистов ввиду неполного и не окончательного понимания его трактовки. Несмотря на это, накоплено достаточно информации, свидетельствующей о том, что выявление в ходе оценки функции внешнего дыхания (ФВД) индекса Генслера (отношение объема форсированного выдоха за 1 сек (ОФВ1) к форсированной жизненной емкости легких (ФЖЕЛ)) ≥70 % и ОФВ1&lt;80 % может рассматриваться предиктором неблагоприятного прогноза для разных категорий пациентов. Исследования последних лет демонстрируют тесные патогенетические взаимосвязи между PRISm и процессом старения, что позволяет рассматривать данный паттерн одним из маркеров возраст-ассоциированных изменений бронхолегочной системы.</p><sec><title>Цель обзора</title><p>Цель обзора: аккумулирование и анализ сведений о спирометрическом паттерне PRISm, представляющем собой потенциально важный диагностический признак для оценки состояния дыхательной системы в возрастном аспекте.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен обзор наиболее релевантных и значимых публикаций, посвященных проблеме PRISm, за последние годы. В статье изложены ключевые сведения о потенциальных этиологических факторах данного спирометрического паттерна, патоморфологических признаках, обсуждены патогенетические связи PRISm с процессом старения.</p></sec><sec><title>Заключение</title><p>Заключение. Спирография остается одним из наиболее информативных методов диагностики бронхолегочных заболеваний, тем не менее выявлению паттерна PRISm, не входящего в привычные классификации патологии дыхательной системы, в реальной клинической практике не уделяется должного внимания. Связь со старением и возможность восстановления нормальных показателей функции внешнего дыхания у лиц с PRISm открывают новые траектории дальнейшего научного поиска терапевтических стратегий в гериатрии.</p></sec></abstract><trans-abstract xml:lang="en"><p>The PRISm spirometry pattern remains a significant challenge for clinicians due to an incomplete and inconsistent understanding of its interpretation. Nevertheless, a substantial body of evidence has been amassed, suggesting that the identification of a forced expiratory volume in one second (FEV1) / forced vital capacity (FVC) ratio ≥70 % (Gaensler index) and FEV1 &lt;80 % during the evaluation of respiratory function can be regarded as a predictor of an unfavourable prognosis for diverse patient categories. Recent studies have demonstrated a close pathogenic relationship between PRISm and the aging process, thus allowing for the consideration of this pattern as a marker of age-associated changes or biological age of the bronchopulmonary system.</p><sec><title>Objective</title><p>Objective: The present study aims to accumulate and analyse information on the PRISm spirometry pattern, with a view to determining its potential as a diagnostic sign for assessing the state of the respiratory system in relation to age.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A comprehensive review of the most pertinent and substantial publications concerning the PRISm problem in recent years was conducted. The article presents key information about potential etiological factors of this spirometry pattern, pathomorphological signs, and discusses pathogenic relationships of PRISm with the aging process.</p></sec><sec><title>Conclusion</title><p>Conclusion. Spirometry remains one of the most informative methods for diagnosing bronchopulmonary diseases; however, the identification of the PRISm pattern, which is not included in  the usual classifications of respiratory system pathology, is not given due attention in real clinical practice. The association between aging and the potential for restoring normal respiratory function in individuals with PRISm introduces new avenues for scientific research in the field of geriatrics, particularly with regard to the development of therapeutic strategies.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>спирометрический паттерн PRISm</kwd><kwd>спирометрия</kwd><kwd>старение</kwd><kwd>дыхательная система</kwd><kwd>хроническая обструктивная болезнь легких</kwd></kwd-group><kwd-group xml:lang="en"><kwd>spirometry pattern PRISm</kwd><kwd>spirometry</kwd><kwd>aging</kwd><kwd>respiratory system</kwd><kwd>chronic obstructive pulmonary disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wan E. S., Castaldi P. J., Cho M. H., et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014 ; 15 (1) : 89 doi: 10.1186/s12931-014-0089-y.</mixed-citation><mixed-citation xml:lang="en">Wan E. S., Castaldi P. J., Cho M. H., et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014 ; 15 (1) : 89 doi: 10.1186/s12931-014-0089-y.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bansal K. L., Bansal S. S., Bansal S., Sahay S. Prevalence of preserved ratio impaired spirometry (PRISM) in patients undergoing spirometry in a medical college hospital. J Med Sci Res. 2023 ; 11 (4) : 296–300. doi: 10.17727/JMSR.2023/11-55.</mixed-citation><mixed-citation xml:lang="en">Bansal K. L., Bansal S. S., Bansal S., Sahay S. Prevalence of preserved ratio impaired spirometry (PRISM) in patients undergoing spirometry in a medical college hospital. J Med Sci Res. 2023 ; 11 (4) : 296–300. doi: 10.17727/JMSR.2023/11-55.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Celli B., Fabbri L., Criner G., et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022 ; 206 (11) : 1317–1325. doi: 10.1164/rccm.202204-0671PP.</mixed-citation><mixed-citation xml:lang="en">Celli B., Fabbri L., Criner G., et al. Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022 ; 206 (11) : 1317–1325. doi: 10.1164/rccm.202204-0671PP.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report [Electronic resource] / Global Initiative for Chronic Obstructive Lung Disease (GOLD). Access mode: https://goldcopd.org/2024-gold-report/, free.</mixed-citation><mixed-citation xml:lang="en">Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report [Electronic resource] / Global Initiative for Chronic Obstructive Lung Disease (GOLD). Access mode: https://goldcopd.org/2024-gold-report/, free.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wijnant S. R. A., De Roos E., Kavousi M., et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020 ; 55 (1) : 1901217 doi: 10.1183/13993003.01217-2019.</mixed-citation><mixed-citation xml:lang="en">Wijnant S. R. A., De Roos E., Kavousi M., et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study. Eur Respir J. 2020 ; 55 (1) : 1901217 doi: 10.1183/13993003.01217-2019.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wan E. S., Balte P., Schwartz J. E., et al. Association between preserved ratio impaired spirometry and clinical outcomes in US Adults. JAMA. 2021 ; 326 (22) : 2287–2298. doi: 10.1001/jama.2021.20939.</mixed-citation><mixed-citation xml:lang="en">Wan E. S., Balte P., Schwartz J. E., et al. Association between preserved ratio impaired spirometry and clinical outcomes in US Adults. JAMA. 2021 ; 326 (22) : 2287–2298. doi: 10.1001/jama.2021.20939.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Choi H., Oak C. H., Jung M. H., et al. Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): nationwide population-based survey between 2010 and 2019 PLoS One. 2024 ; 19 (7) : e0307302. doi: 10.1371/ journal.pone.0307302.</mixed-citation><mixed-citation xml:lang="en">Choi H., Oak C. H., Jung M. H., et al. Trend of prevalence and characteristics of preserved ratio impaired spirometry (PRISm): nationwide population-based survey between 2010 and 2019 PLoS One. 2024 ; 19 (7) : e0307302. doi: 10.1371/ journal.pone.0307302.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tanabe N., Masuda I., Shiraishi Y., et al. Clinical relevance of multiple confirmed preserved ratio impaired spirometry cases in adults. Respir Investig. 2022 ; 60 (6) : 822–830 doi: 10.1016/j.resinv.2022.08.006.</mixed-citation><mixed-citation xml:lang="en">Tanabe N., Masuda I., Shiraishi Y., et al. Clinical relevance of multiple confirmed preserved ratio impaired spirometry cases in adults. Respir Investig. 2022 ; 60 (6) : 822–830 doi: 10.1016/j.resinv.2022.08.006.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Xu H., Jiang X., Zeng Q., Li R. Associated Factors and Pulmonary Function Outcomes of Preserved Ratio Impaired Spirometry: A Scoping Review. Int J Chron Obstruct Pulmon Dis. 2025 ; 20 : 767–784. doi: 10.2147/COPD.S506115.</mixed-citation><mixed-citation xml:lang="en">Xu H., Jiang X., Zeng Q., Li R. Associated Factors and Pulmonary Function Outcomes of Preserved Ratio Impaired Spirometry: A Scoping Review. Int J Chron Obstruct Pulmon Dis. 2025 ; 20 : 767–784. doi: 10.2147/COPD.S506115.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miura S., Iwamoto H., Omori K., et al. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality. Sci Rep. 2023 ; 13 (1) : 2988 doi: 10.1038/ s41598-023-29922-0.</mixed-citation><mixed-citation xml:lang="en">Miura S., Iwamoto H., Omori K., et al. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality. Sci Rep. 2023 ; 13 (1) : 2988 doi: 10.1038/ s41598-023-29922-0.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Marott J. L., Ingebrigtsen T. S., Çolak Y., et al. Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. Am J Respir Crit Care Med. 2021 ; 204 (8) : 910–920. doi: 10.1164/rccm.202102-0517OC.</mixed-citation><mixed-citation xml:lang="en">Marott J. L., Ingebrigtsen T. S., Çolak Y., et al. Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis. Am J Respir Crit Care Med. 2021 ; 204 (8) : 910–920. doi: 10.1164/rccm.202102-0517OC.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shiraishi Y., Shimada T., Tanabe N., et al. The prevalence and physiological impacts of centrilobular and paraseptal emphysema on computed tomography in smokers with preserved ratio impaired spirometry. ERJ Open Res. 2022 ; 8 (2) : 00063–2022. doi: 10.1183/23120541.00063-2022.</mixed-citation><mixed-citation xml:lang="en">Shiraishi Y., Shimada T., Tanabe N., et al. The prevalence and physiological impacts of centrilobular and paraseptal emphysema on computed tomography in smokers with preserved ratio impaired spirometry. ERJ Open Res. 2022 ; 8 (2) : 00063–2022. doi: 10.1183/23120541.00063-2022.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J., Li W., Sun Y., et al. Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2024 ; 19 : 753–764. doi: 10.2147/COPD.S453086.</mixed-citation><mixed-citation xml:lang="en">Huang J., Li W., Sun Y., et al. Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2024 ; 19 : 753–764. doi: 10.2147/COPD.S453086.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">de Barros Mendes Lopes T., Groth E. E., Veras M., et al. Pre- and postnatal exposure of mice to concentrated urban PM2.5 decreases the number of alveoli and leads to altered lung function at an early stage of life. Environ Pollut. 2018 ; 241 : 511–520. doi: 10.1016/j.envpol.2018.05.055.</mixed-citation><mixed-citation xml:lang="en">de Barros Mendes Lopes T., Groth E. E., Veras M., et al. Pre- and postnatal exposure of mice to concentrated urban PM2.5 decreases the number of alveoli and leads to altered lung function at an early stage of life. Environ Pollut. 2018 ; 241 : 511–520. doi: 10.1016/j.envpol.2018.05.055.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shah N. M., Kaltsakas G. Respiratory complications of obesity: from early changes to respiratory failure. Breathe (Sheff ). 2023 ; 19 (1) : 220263 doi: 10.1183/20734735.0263-2022.</mixed-citation><mixed-citation xml:lang="en">Shah N. M., Kaltsakas G. Respiratory complications of obesity: from early changes to respiratory failure. Breathe (Sheff ). 2023 ; 19 (1) : 220263 doi: 10.1183/20734735.0263-2022.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Dixon A. E., Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018 ; 12 (9) : 755–767. doi: 1 0.1080/17476348.2018.1506331.</mixed-citation><mixed-citation xml:lang="en">Dixon A. E., Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018 ; 12 (9) : 755–767. doi: 1 0.1080/17476348.2018.1506331.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tashiro H., Kurihara Y., Kuwahara Y., Takahashi K. Impact of obesity in asthma: Possible future therapies. Allergol Int. 2024 ; 73 (1) : 48–57. doi: 10.1016/j.alit.2023.08.007.</mixed-citation><mixed-citation xml:lang="en">Tashiro H., Kurihara Y., Kuwahara Y., Takahashi K. Impact of obesity in asthma: Possible future therapies. Allergol Int. 2024 ; 73 (1) : 48–57. doi: 10.1016/j.alit.2023.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vozoris N. T. 1., O’Donnell D. E. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J. 2012 ; 19 (3) : e18–24. doi: 10.1155/2012/732618.</mixed-citation><mixed-citation xml:lang="en">Vozoris N. T. 1., O’Donnell D. E. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with chronic obstructive pulmonary disease. Can Respir J. 2012 ; 19 (3) : e18–24. doi: 10.1155/2012/732618.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Verberne L. D. M., Leemrijse C. J., Swinkels I. C. S., et al. Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice. NPJ Prim Care Respir Med. 2017 ; 27 (1) : 63 doi: 10.1038/s41533-017-0065-3.</mixed-citation><mixed-citation xml:lang="en">Verberne L. D. M., Leemrijse C. J., Swinkels I. C. S., et al. Overweight in patients with chronic obstructive pulmonary disease needs more attention: a cross-sectional study in general practice. NPJ Prim Care Respir Med. 2017 ; 27 (1) : 63 doi: 10.1038/s41533-017-0065-3.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Grigsby M. R., Siddharthan T., Pollard S. L., et al. Low Body Mass Index Is Associated with Higher Odds of COPD and Lower Lung Function in Low- and Middle-Income Countries. COPD. 2019 ; 16 (1) : 58–65. doi: 10.1080/15412555.2019.158 9443</mixed-citation><mixed-citation xml:lang="en">Grigsby M. R., Siddharthan T., Pollard S. L., et al. Low Body Mass Index Is Associated with Higher Odds of COPD and Lower Lung Function in Low- and Middle-Income Countries. COPD. 2019 ; 16 (1) : 58–65. doi: 10.1080/15412555.2019.158 9443</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Alif S. M., Dharmage S., Benke G., et al. Occupational exposure to solvents and lung function decline: A population based study. Thorax. 2019 ; 74 (7) : 650–658. doi: 10.1136/thoraxjnl-2018-212267.</mixed-citation><mixed-citation xml:lang="en">Alif S. M., Dharmage S., Benke G., et al. Occupational exposure to solvents and lung function decline: A population based study. Thorax. 2019 ; 74 (7) : 650–658. doi: 10.1136/thoraxjnl-2018-212267.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Gan W. Q., Man S. F., Postma D. S., et al. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006 ; 7 (1) : 52 doi: 10.1186/ 1465-9921-7-52.</mixed-citation><mixed-citation xml:lang="en">Gan W. Q., Man S. F., Postma D. S., et al. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006 ; 7 (1) : 52 doi: 10.1186/ 1465-9921-7-52.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Prescott E., Bjerg A. M., Andersen P. K., et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997 ; 10 (4) : 822–827.</mixed-citation><mixed-citation xml:lang="en">Prescott E., Bjerg A. M., Andersen P. K., et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997 ; 10 (4) : 822–827.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Scanlon P. D., Connett J. E., Waller L. A., et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000 ; 161 (2 Pt 1) : 381–390. doi: 10.1164/ajrccm.161.2.9901044.</mixed-citation><mixed-citation xml:lang="en">Scanlon P. D., Connett J. E., Waller L. A., et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000 ; 161 (2 Pt 1) : 381–390. doi: 10.1164/ajrccm.161.2.9901044.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Han M. K., Postma D., Mannino D. M., et al . Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007 ; 176 (12) : 1179–1184. doi: 10.1164/ rccm.200704-553CC.</mixed-citation><mixed-citation xml:lang="en">Han M. K., Postma D., Mannino D. M., et al . Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007 ; 176 (12) : 1179–1184. doi: 10.1164/ rccm.200704-553CC.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Burrows B., Bloom J. W., Traver G. A., Cline M. G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 ; 317 (21) : 1309–1314. doi: 10.1056/ NEJM198711193172103.</mixed-citation><mixed-citation xml:lang="en">Burrows B., Bloom J. W., Traver G. A., Cline M. G. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987 ; 317 (21) : 13091314. doi: 10.1056/ NEJM198711193172103.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева В. А., Булгакова С. В. Хроническая обструктивная болезнь легких: принципы терапии пожилых пациентов. // Успехи геронтологии. — 2025. — Т. 38, № 1. — С. 87–95.</mixed-citation><mixed-citation xml:lang="en">Sergeeva V. A., Bulgakova S. V. Chronic Obstructive Pulmonary Disease:Principles of Treatment in Elderly Patients. Adv. geront. 2025 ; 38 (1) : 87–95. (In Russ.). doi: 10.34922/ AE.2025.38.1.010.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева В. А., Рунихина Н. К. Патогенетические и клинические взаимосвязи хронической обструктивной болезни легких, саркопении и старческой астении. // Российский журнал гериатрической медицины. — 2024. — Т. 1, № 17 С. 40–48.</mixed-citation><mixed-citation xml:lang="en">Sergeeva V. A., Runikhina N. K. Pathogenetic and Clinical Relationships between Chronic Obstructive Pulmonary Disease, Sarcopenia and Frailty. Russian Journal of Geriatric Medicine. 2024 ; 1 (17) : 40–48. (In Russ.). doi: 10.37586/2686-8636-1-2024-40-48.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lei J., Huang K., Wu S., et al. Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study. Lancet Reg Health West Pac. 2024 ; 45 : 101021 doi: 10.1016/j. lanwpc.2024.101021.</mixed-citation><mixed-citation xml:lang="en">Lei J., Huang K., Wu S., et al. Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study. Lancet Reg Health West Pac. 2024 ; 45 : 101021 doi: 10.1016/j. lanwpc.2024.101021.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cestelli L., Johannessen A., Gulsvik A., et al. Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern. Chest. 2025 ; 167 (2) : 548–560. doi: 10.1016/j.chest.2024.08.026.</mixed-citation><mixed-citation xml:lang="en">Cestelli L., Johannessen A., Gulsvik A., et al. Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern. Chest. 2025 ; 167 (2) : 548–560. doi: 10.1016/j.chest.2024.08.026.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Morales P., Furest I., Marco V., et al. Pathogenesis of the lung in restrictive defects of Klinefelter's syndrome. Chest. 1992 ; 102 (5) : 1550–1552. doi: 10.1378/chest.102.5.1550.</mixed-citation><mixed-citation xml:lang="en">Morales P., Furest I., Marco V., et al. Pathogenesis of the lung in restrictive defects of Klinefelter's syndrome. Chest. 1992 ; 102 (5) : 1550–1552. doi: 10.1378/chest.102.5.1550.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lai Y., Yang T., Zhang X., Li M. Associations between life's essential 8 and preserved ratio impaired spirometry. Sci Rep. 2025 ;15 (1) : 8166 doi: 10.1038/s41598-025-90381-w.</mixed-citation><mixed-citation xml:lang="en">Lai Y., Yang T., Zhang X., Li M. Associations between life's essential 8 and preserved ratio impaired spirometry. Sci Rep. 2025 ;15 (1) : 8166 doi: 10.1038/s41598-025-90381-w.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Wan E. S., Hokanson J. E., Murphy J. R., et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011 ; 184 (1) : 57–63. doi: 10.1164/rccm.201101-0021OC.</mixed-citation><mixed-citation xml:lang="en">Wan E. S., Hokanson J. E., Murphy J. R., et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011 ; 184 (1) : 57–63. doi: 10.1164/rccm.201101-0021OC.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wan E. S., Fortis S., Regan E. A., et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018 ; 198 (11) : 1397–1405. doi: 10.1164/rccm.201804-0663OC.</mixed-citation><mixed-citation xml:lang="en">Wan E. S., Fortis S., Regan E. A., et al. Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study. Am J Respir Crit Care Med. 2018 ; 198 (11) : 1397–1405. doi: 10.1164/rccm.201804-0663OC.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S. S., Yagihashi K., Stinson D. S., et al. Visual assessment of CT findings in smokers with nonobstructedspirometric abnormalities in the COPDGene® study. Chronic Obstr Pulm Dis. 2014 ; 1 (1) : 88–96. doi: 10.15326/jcopdf.1.1.2013.0001#sthash.L0atdpjM.dpuf.</mixed-citation><mixed-citation xml:lang="en">Kim S. S., Yagihashi K., Stinson D. S., et al. Visual assessment of CT findings in smokers with nonobstructedspirometric abnormalities in the COPDGene® study. Chronic Obstr Pulm Dis. 2014 ; 1 (1) : 88–96. doi: 10.15326/jcopdf.1.1.2013.0001#sthash.L0atdpjM.dpuf.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kim J., Lee C. H., Lee H. Y., Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean national health and nutrition examination survey IV– VI. Respiration. 2022 ; 101 (1) : 25–33. doi: 10.1159/000517599.</mixed-citation><mixed-citation xml:lang="en">Kim J., Lee C. H., Lee H. Y., Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean national health and nutrition examination survey IV– VI. Respiration. 2022 ; 101 (1) : 25–33. doi: 10.1159/000517599.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Roman M. A., Rossiter H. B., Casaburi R. Exercise, ageing and the lung. Eur Respir J. 2016 ; 48 (5) : 1471–1486. doi: 10.1183/13993003.00347-2016.</mixed-citation><mixed-citation xml:lang="en">Roman M. A., Rossiter H. B., Casaburi R. Exercise, ageing and the lung. Eur Respir J. 2016 ; 48 (5) : 1471–1486. doi: 10.1183/13993003.00347-2016.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Janssens J. P., Pache J. C., Nicod L. P. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999 ; 13 (1) : 197–205. doi: 10.1034/j.1399-3003.1999.13a36.x.</mixed-citation><mixed-citation xml:lang="en">Janssens J. P., Pache J. C., Nicod L. P. Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999 ; 13 (1) : 197–205. doi: 10.1034/j.1399-3003.1999.13a36.x.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеева В. А., Рунихина Н. К. Респираторная саркопения: патогенетические аспекты, подходы к диагностике. // Пульмонология. –2024. — Т. 34, № 6. — С. 869–878.</mixed-citation><mixed-citation xml:lang="en">Sergeeva V. A., Runikhina N. K. Respiratory sarcopenia: aspects of pathogenesis, approaches to diagnosis. Pul’monologiya. 2024 ; 34 (6) : 869–878 (InRuss.). doi: 10.18093/0869-0189-2024-4271.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson P., Siddharthan T. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J. 2020 ; 55 (4) : 2000184 doi: 10.1183/13993003.00184-2020.</mixed-citation><mixed-citation xml:lang="en">Jackson P., Siddharthan T. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J. 2020 ; 55 (4) : 2000184 doi: 10.1183/13993003.00184-2020.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wijnant S. R. A., Lahousse L., Brusselle G. G. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J. 2020 ; 55 : 2000354 doi: 10.1183/13993003.00354-2020.</mixed-citation><mixed-citation xml:lang="en">Wijnant S. R. A., Lahousse L., Brusselle G. G. The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation. Eur Respir J. 2020 ; 55 : 2000354 doi: 10.1183/13993003.00354-2020.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wannamethee S. G., Shaper A. G., Rumley A., et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care. 2010 ; 33 (9) : 1990–1996. doi: 10.2337/dc10-0324.</mixed-citation><mixed-citation xml:lang="en">Wannamethee S. G., Shaper A. G., Rumley A., et al. Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation. Diabetes Care. 2010 ; 33 (9) : 1990–1996. doi: 10.2337/dc10-0324.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kalhan R., Tran B. T., Colangelo L. A., et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010 ; 5 (7) : e11431. doi: 10.1371/journal.pone.0011431. Correction: Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age. PLoS One. 2010 ; 5 (8): 10.1371/annotation/ed92662b-c566-488d-b090-6c80046d3499. doi: 10.1371/annotation/ed92662b-c566-488d-b090-6c80046d3499.</mixed-citation><mixed-citation xml:lang="en">Kalhan R., Tran B. T., Colangelo L. A., et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010 ; 5 (7) : e11431. doi: 10.1371/journal.pone.0011431. Correction: Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age. PLoS One. 2010 ; 5 (8): 10.1371/annotation/ed92662b-c566-488d-b090-6c80046d3499. doi: 10.1371/annotation/ed92662b-c566-488d-b090-6c80046d3499.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Jin Q., Zhang Z., Zhou T., et al. Preserved ratio impaired spirometry: clinical, imaging and artificial intelligence perspective. J Thorac Dis. 2025 ; 17 (1) : 450–460. doi: 10.21037/jtd-24-1582.</mixed-citation><mixed-citation xml:lang="en">Jin Q., Zhang Z., Zhou T., et al. Preserved ratio impaired spirometry: clinical, imaging and artificial intelligence perspective. J Thorac Dis. 2025 ; 17 (1) : 450–460. doi: 10.21037/jtd-24-1582.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Li D., Ruan Z., Xie S., et al. The relationship between preserved ratio impaired spirometry and mortality in the myocardial infarction survivors: a population-based cohort study. BMC Cardiovasc Disord. 2023 ; 23 (1) : 331 doi: 10.1186/s12872-023-03352-2.</mixed-citation><mixed-citation xml:lang="en">Li D., Ruan Z., Xie S., et al. The relationship between preserved ratio impaired spirometry and mortality in the myocardial infarction survivors: a population-based cohort study. BMC Cardiovasc Disord. 2023 ; 23 (1) : 331 doi: 10.1186/s12872-023-03352-2.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kaise T., Sakihara E., Tamaki K., et al. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study. Int J Chron Obstruct Pulmon Dis. 2021 ; 16 : 2665–2675. doi: 10.2147/COPD.S322041.</mixed-citation><mixed-citation xml:lang="en">Kaise T., Sakihara E., Tamaki K., et al. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study. Int J Chron Obstruct Pulmon Dis. 2021 ; 16 : 2665–2675. doi: 10.2147/COPD.S322041.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Pellegrino D., Casas-Recasens S., Faner R., et al. When GETomics meets aging and exercise in COPD. Respir Med. 2023 ; 216 : 107294 doi: 10.1016/j.rmed.2023.107294.</mixed-citation><mixed-citation xml:lang="en">Pellegrino D., Casas-Recasens S., Faner R., et al. When GETomics meets aging and exercise in COPD. Respir Med. 2023 ; 216 : 107294 doi: 10.1016/j.rmed.2023.107294.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">He D., Yan M., Zhou Y., et al. Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study. Chest. 2024 ; 165 (3) : 573– 582 doi: 10.1016/j.chest.2023.07.020.</mixed-citation><mixed-citation xml:lang="en">He D., Yan M., Zhou Y., et al. Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence From a Prospective Cohort Study. Chest. 2024 ; 165 (3) : 573– 582 doi: 10.1016/j.chest.2023.07.020.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wijnant S. R. A., Benz E., Luik A. I., et al. Frailty Transitions in Older Persons With Lung Function Impairment: A Population-Based Study. J Gerontol A BiolSci Med Sci. 2023 ; 78 (2) : 349–356. doi: 10.1093/gerona/glac202.</mixed-citation><mixed-citation xml:lang="en">Wijnant S. R. A., Benz E., Luik A. I., et al. Frailty Transitions in Older Persons With Lung Function Impairment: A Population-Based Study. J Gerontol A BiolSci Med Sci. 2023 ; 78 (2) : 349–356. doi: 10.1093/gerona/glac202.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Anami K., Murata S., Nakano H., et al. Physical performance in relation to preserved ratio impaired spirometry: a cross-sectional study of community-dwelling older Japanese adults. Sci Rep. 2021 ; 11 (1) : 17411 doi: 10.1038/ s41598-021-96830-6.</mixed-citation><mixed-citation xml:lang="en">Anami K., Murata S., Nakano H., et al. Physical performance in relation to preserved ratio impaired spirometry: a cross-sectional study of community-dwelling older Japanese adults. Sci Rep. 2021 ; 11 (1) : 17411 doi: 10.1038/ s41598-021-96830-6.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Kakehi S., Wakabayashi H., Inuma H., et al. Rehabilitation Nutrition and Exercise Therapy for Sarcopenia. World J Mens Health. 2022 ; 40 (1) : 1–10. doi: 10.5534/wjmh.200190.</mixed-citation><mixed-citation xml:lang="en">Kakehi S., Wakabayashi H., Inuma H., et al. Rehabilitation Nutrition and Exercise Therapy for Sarcopenia. World J Mens Health. 2022 ; 40 (1) : 1–10. doi: 10.5534/wjmh.200190.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ткачева О. Н., Рунихина Н. К., Малая И. П. и др. Гериатрическая реабилитация пациентов c синдромом старческой астении: промежуточные результаты открытого проспективного исследования «ПОСТСКРИПТУМ». // Вестник восстановительной медицины. — 2024. — Т. 23, № 6. — С. 8–18.</mixed-citation><mixed-citation xml:lang="en">Tkacheva O. N., Runikhina N. K., Malaya I. P., et al. Geriatric Rehabilitation in Patients with Frailty: Interim Results of the POSTSCRIPTUM. An Open Prospective Study. Bulletin of Rehabilitation Medicine. 2024 ; 23 (6) : 8–18.(In Russ.). doi: 10.38025/2078-1962-2024-23-6-8-18.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Liwsrisakun C., Chaiwong W., Deesomchok A., et al. The Role of Impulse Oscillometry in Detection of Preserved Ratio Impaired Spirometry (PRISm). Adv Respir Med. 2025 ; 93 (1) : 2 doi: 10.3390/arm93010002.</mixed-citation><mixed-citation xml:lang="en">Liwsrisakun C., Chaiwong W., Deesomchok A., et al. The Role of Impulse Oscillometry in Detection of Preserved Ratio Impaired Spirometry (PRISm). Adv Respir Med. 2025 ; 93 (1) : 2 doi: 10.3390/arm93010002.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
